Exiqon publishes validation data from study of biomarkers

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Exiqon publishes validation data from study of biomarkers for prostate cancer

Copenhagen, 2016-04-25 08:18 CEST (GLOBE NEWSWIRE) -- Exiqon A/S (NASDAQ OMX: EXQ), a leading provider of flexible solutions for RNA analysis, today announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.

The biomarker profile consists of 3 microRNAs which may be readily assayed with Exiqon’s proprietary PCR technology using prostate cancer tissue obtained by radical prostatectomy. The published biomarker profile can group patients into “high” and “low” risk groups of which patients in the “low” risk group are expected to have a non-aggressive disease. More than half of the patients were categorized as being “low” risk with an accuracy of 80-89%.  

The published biomarker profile works independently of current clinicopathological parameters and is therefore likely to add value to current clinical practice.

 “ At Exiqon, we share the vison of validating biomarkers together with the medical community to facilitate the implementation of personalized medicine. With the increasing cost of treating complex diseases such as prostate cancer there is a significant market need for tests that enable the medical community to focus the sparse resources on the relevant patients only ” said Peter Mouritzen, VP Product Development, Exiqon A/S.

For several years, Exiqon and Aarhus University Hospital have been working together on identifying and validating novel prognostic biomarkers for prostate cancer. The study published in Oncotarget describes the prognostic biomarker profile validated in three independent cohorts: http://goo.gl/n7Dx9y

 “ As many as 90% of the patients who today undergo operation for prostate cancer may avoid operation if biomarkers could provide information on the aggressiveness of the disease ” said Torben Ørntoft, Professor Aarhus University Hospital.

Prostate cancer is the most frequent cancer among men, reflective of approximately 14% lifetime risk of getting prostate cancer. Fortunately, most prostate cancers are not aggressive. However, the lack of effective prognostic biomarkers results in significant overtreatment. Treatment of prostate cancer results in decreased life quality and comes at significant costs. Prostate cancer treatment costs between 20,000 USD and 140,000 USD per patient. With 1 million patients diagnosed with prostate cancer every year the market opportunity for a prognostic test amounts to approximately USD 750 million.

Exiqon is currently conducting analytic validation to document the robustness of the test. In parallel, additional patient cohorts are being recruited from Europe and the US to further strengthen the clinical validation. A commercial test may become available in 2017.

Additional information

Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)

Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2131)

About Exiqon

At Exiqon, we advance the research of when and where genes are expressed. We empower scientists across the world with best-in-class products and user-friendly business solutions designed to transform workflows in our industry. Exiqon operates in two business areas: Exiqon Life Sciences is a leading provider of flexible solutions for gene expression analysis. Academia, biotech and pharmaceutical companies around the world use Exiqon’s research products to make ground-breaking discoveries. Exiqon Diagnostics collaborates with diagnostic and pharmaceutical companies to develop novel molecular diagnostic tests for early detection of diseases, which can help physicians make better treatment decisions. Exiqon is listed on Nasdaq Copenhagen. For more information about us, please visit www.exiqon.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Gates Industrial's Q3 2025 Report Highlights Growth Trends

Updated Category News Views 205

Gates Industrial's Financial Performance Overview Gates Industrial Corporation plc (NYSE: GTES), a prominent global supplier of fluid power and power transmission solutions, reported its financial results for the third quarter ending September 27, 2025. This announcement showcases the company’s robust performance and strategic initiatives aimed at long-term growth. Key...

Continue Reading
Bitfarms and Riot Forge New Agreement to Enhance Governance

Updated Category News Views 62

Important Changes in Governance at Bitfarms and Riot Bitfarms Ltd. (NASDAQ: BITF) and Riot Platforms Inc. (NASDAQ: RIOT) have made headlines with a new settlement focused on improving their governance structures. This significant development demonstrates both companies' commitment to evolving with the rapidly changing cryptocurrency landscape, setting the stage for...

Continue Reading
Sri Lanka Maintains Steady Interest Rates Amid New Leadership

Updated Category News Views 162

Sri Lanka's central bank decided to keep interest rates steady back in late 2024, amidst a backdrop of economic turbulence and the arrival of new political leadership. The Central Bank of Sri Lanka (CBSL) opted to maintain the Standing Deposit Facility Rate at 8.25% and the Standing Lending Facility Rate at 9.25%. This cautious approach reflects a critical moment for...

Continue Reading
Seasun Games' Mecha Break: A Global Gaming Phenomenon

Updated Category News Views 197

Seasun Games Takes Center Stage with Mecha Break Seasun Games, a venerable name in the gaming industry with a rich history spanning over thirty years, recently made waves at the China Digital Entertainment Expo & Conference, known as ChinaJoy. During this vibrant event held in Shanghai, the company unveiled its latest title, Mecha Break, capturing the imagination of...

Continue Reading
Rohrer Corporation Welcomes Drew Pansa as VP of Corporate Growth

Updated Category News Views 423

Rohrer Corporation Names Drew Pansa as New Vice President Rohrer Corporation, a prominent player in retail packaging design and manufacturing, has strengthened its leadership team by appointing Drew Pansa as Vice President of Corporate Development. Drew brings a wealth of experience in mergers and acquisitions, showcasing a strong track record in driving growth through...

Continue Reading